Sandra M. McLachlan

11.7k total citations · 1 hit paper
253 papers, 9.0k citations indexed

About

Sandra M. McLachlan is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sandra M. McLachlan has authored 253 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Endocrinology, Diabetes and Metabolism, 94 papers in Immunology and 82 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sandra M. McLachlan's work include Thyroid Disorders and Treatments (135 papers), Monoclonal and Polyclonal Antibodies Research (82 papers) and T-cell and B-cell Immunology (62 papers). Sandra M. McLachlan is often cited by papers focused on Thyroid Disorders and Treatments (135 papers), Monoclonal and Polyclonal Antibodies Research (82 papers) and T-cell and B-cell Immunology (62 papers). Sandra M. McLachlan collaborates with scholars based in United States, United Kingdom and Japan. Sandra M. McLachlan's co-authors include Basil Rapoport, Gregorio D. Chazenbalk, Bernard Rees Smith, B Rapoport, Chun‐Rong Chen, Juan Carlos Jaume, Yuji Nagayama, Pavel N. Pichurin, Jadwiga Furmaniak and Holly A. Aliesky and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Sandra M. McLachlan

250 papers receiving 8.6k citations

Hit Papers

Autoantibodies to the Thyrotropin Receptor 1988 2026 2000 2013 1988 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Autoantibodies to the Thyrotropin Receptor
    1988 496 citations Sandra M. McLachlan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra M. McLachlan United States 49 5.3k 2.8k 2.3k 2.1k 2.0k 253 9.0k
Basil Rapoport United States 48 4.7k 0.9× 1.8k 0.6× 2.5k 1.1× 1.3k 0.6× 1.5k 0.8× 216 7.6k
Yuji Nagayama Japan 47 3.8k 0.7× 1.8k 0.6× 2.6k 1.1× 869 0.4× 1.7k 0.8× 206 7.5k
Joel S. Hayflick United States 30 792 0.1× 1.9k 0.7× 4.3k 1.9× 1.1k 0.5× 1.2k 0.6× 42 8.0k
Hiroshi Shibuyà Japan 49 1.0k 0.2× 2.3k 0.8× 8.0k 3.4× 201 0.1× 1.0k 0.5× 136 12.1k
Eric J. Jenkinson United Kingdom 56 983 0.2× 6.6k 2.4× 2.8k 1.2× 518 0.2× 904 0.5× 170 10.2k
Tracy A. Willson Australia 43 622 0.1× 4.3k 1.5× 4.8k 2.1× 198 0.1× 959 0.5× 74 11.1k
Micheline Misrahi France 45 1.8k 0.3× 729 0.3× 3.0k 1.3× 354 0.2× 2.3k 1.2× 110 6.7k
Albert Beckers Belgium 54 7.5k 1.4× 368 0.1× 1.5k 0.6× 381 0.2× 583 0.3× 335 10.5k
Achim Leutz Germany 51 698 0.1× 2.5k 0.9× 6.5k 2.8× 155 0.1× 1.4k 0.7× 116 10.0k
Dhavalkumar D. Patel United States 42 508 0.1× 3.0k 1.1× 2.3k 1.0× 236 0.1× 1.2k 0.6× 67 6.7k

Countries citing papers authored by Sandra M. McLachlan

Since Specialization
Citations

This map shows the geographic impact of Sandra M. McLachlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra M. McLachlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra M. McLachlan more than expected).

Fields of papers citing papers by Sandra M. McLachlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra M. McLachlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra M. McLachlan. The network helps show where Sandra M. McLachlan may publish in the future.

Co-authorship network of co-authors of Sandra M. McLachlan

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra M. McLachlan. A scholar is included among the top collaborators of Sandra M. McLachlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra M. McLachlan. Sandra M. McLachlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McLachlan, Sandra M. & Basil Rapoport. (2022). Discoveries in Thyroid Autoimmunity in the Past Century. Thyroid. 33(3). 278–286. 4 indexed citations
2.
Bahn, Rebecca S., Tabitha Doniach, & Sandra M. McLachlan. (2020). Deborah Doniach: Discovering Thyroid Autoimmunity: The End of Horror Autotoxicus. Thyroid. 30(7). 942–947.
3.
McLachlan, Sandra M., Holly A. Aliesky, & Basil Rapoport. (2019). Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.H2h4 Mice. The Journal of Immunology. 202(9). 2570–2577. 6 indexed citations
4.
McLachlan, Sandra M., Holly A. Aliesky, & Basil Rapoport. (2019). A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans. Thyroid. 29(8). 1138–1146. 1 indexed citations
5.
Rapoport, Basil, et al.. (2015). A Unique Mouse Strain That Develops Spontaneous, Iodine-Accelerated, Pathogenic Antibodies to the Human Thyrotrophin Receptor. The Journal of Immunology. 194(9). 4154–4161. 29 indexed citations
6.
McLachlan, Sandra M., Holly A. Aliesky, Chun‐Rong Chen, & Basil Rapoport. (2012). Role of Self-Tolerance and Chronic Stimulation in the Long-Term Persistence of Adenovirus-Induced Thyrotropin Receptor Antibodies in Wild-Type and Transgenic Mice. Thyroid. 22(9). 931–937. 11 indexed citations
7.
Chen, Chun‐Rong, Holly A. Aliesky, Basil Rapoport, & Sandra M. McLachlan. (2011). An Attempt to Induce “Graves' Disease of the Gonads” by Immunizing Mice with the Luteinizing Hormone Receptor Provides Insight into Breaking Tolerance to Self-Antigens. Thyroid. 21(7). 773–781. 3 indexed citations
8.
Hamidi, Sepehr, Holly A. Aliesky, Chun‐Rong Chen, Basil Rapoport, & Sandra M. McLachlan. (2010). Variable Suppression of Serum Thyroxine in Female Mice of Different Inbred Strains by Triiodothyronine Administered in Drinking Water. Thyroid. 20(10). 1157–1162. 15 indexed citations
9.
Hamidi, Sepehr, et al.. (2010). Relationship between Thyrotropin Receptor Hinge Region Proteolytic Posttranslational Modification and Receptor Physiological Function. Molecular Endocrinology. 25(1). 184–194. 16 indexed citations
10.
Misharin, Alexander V., Basil Rapoport, & Sandra M. McLachlan. (2009). Thyroid Antigens, Not Central Tolerance, Control Responses to Immunization in BALB/c Versus C57BL/6 Mice. Thyroid. 19(5). 503–509. 10 indexed citations
11.
Pichurin, Pavel N., Chun-Rong Chen, Gregorio D. Chazenbalk, et al.. (2006). Targeted Expression of the Human Thyrotropin Receptor A-Subunit to the Mouse Thyroid: Insight into Overcoming the Lack of Response to A-Subunit Adenovirus Immunization. The Journal of Immunology. 176(1). 668–676. 22 indexed citations
12.
Quaratino, Sonia, Jean Ruf, Mohamed Osman, et al.. (2005). Human Autoantibodies Modulate the T Cell Epitope Repertoire but Fail to Unmask a Pathogenic Cryptic Epitope. The Journal of Immunology. 174(1). 557–563. 21 indexed citations
13.
Nagayama, Yuji, Kanji Watanabe, Masami Niwa, Sandra M. McLachlan, & Basil Rapoport. (2004). Schistosoma mansoni and α-Galactosylceramide: Prophylactic Effect of Th1 Immune Suppression in a Mouse Model of Graves’ Hyperthyroidism. The Journal of Immunology. 173(3). 2167–2173. 85 indexed citations
14.
Nagayama, Yuji, Hiroyuki Mizuguchi, Takao Hayakawa, et al.. (2003). Prevention of Autoantibody-Mediated Graves’-Like Hyperthyroidism in Mice with IL-4, a Th2 Cytokine. The Journal of Immunology. 170(7). 3522–3527. 77 indexed citations
15.
Chazenbalk, Gregorio D., Pavel N. Pichurin, Chun‐Rong Chen, et al.. (2002). Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. Journal of Clinical Investigation. 110(2). 209–217. 115 indexed citations
16.
Chazenbalk, Gregorio D., Pavel N. Pichurin, Chun‐Rong Chen, et al.. (2002). Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. Journal of Clinical Investigation. 110(2). 209–217. 90 indexed citations
17.
Pichurin, Pavel N., Xinmin Yan, Loredana Farilla, et al.. (2001). Naked TSH Receptor DNA Vaccination: A TH1 T Cell Response in Which Interferon-γ Production, Rather than Antibody, Dominates the Immune Response in Mice. Endocrinology. 142(8). 3530–3536. 51 indexed citations
18.
19.
Chazenbalk, Gregorio D., Kunihiko Tanaka, Sandra M. McLachlan, & Basil Rapoport. (1999). On the Functional Importance of Thyrotropin Receptor Intramolecular Cleavage1. Endocrinology. 140(10). 4516–4520. 38 indexed citations
20.
McLachlan, Sandra M.. (1996). Monoclonal, human autoantibodies to the TSH receptor--the Holy Grail and why are we looking for it?. The Journal of Clinical Endocrinology & Metabolism. 81(9). 3152–3154. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Basil Rapoport Breakdown of academic impact, for papers by Yuji Nagayama Breakdown of academic impact, for papers by Joel S. Hayflick Breakdown of academic impact, for papers by Hiroshi Shibuyà Breakdown of academic impact, for papers by Eric J. Jenkinson Breakdown of academic impact, for papers by Tracy A. Willson Breakdown of academic impact, for papers by Micheline Misrahi Breakdown of academic impact, for papers by Albert Beckers Breakdown of academic impact, for papers by Achim Leutz Breakdown of academic impact, for papers by Dhavalkumar D. Patel
Rankless by CCL
2026